Fertility News and Research

RSS

Potential connection between autism and insulin-like growth factor

A New York-based physician-researcher from Touro College of Osteopathic Medicine, best known for his research into fertility and twinning, has uncovered a potential connection between autism and a specific growth protein that could eventually be used as a way to predict an infant's propensity to later develop the disease.

2 Feb 2013

Enterprise Ireland welcomes Irish Minister to its pavilion at Arab Health 2013

Enterprise Ireland Dubai, the regional arm of the Irish government organisation responsible for the development and growth of Irish enterprises in world markets, welcomed Minister Costello TD, Irish Minister of State for Trade and Development to its pavilion at this year's Arab Health exhibition.

30 Jan 2013

Postpartum hemorrhage does not impact future pregnancies

Postpartum hemorrhage with a first pregnancy does not have a detrimental effect on second pregnancies, research shows.

29 Jan 2013

Women with BRCA gene mutations tend to undergo menopause sooner than others

Women with harmful mutations in the BRCA gene, which put them at higher risk of developing breast and ovarian cancer, tend to undergo menopause significantly sooner than other women, allowing them an even briefer reproductive window and possibly a higher risk of infertility, according to a study led by researchers at UC San Francisco.

29 Jan 2013

Vejthani ART Center provides innovative and high quality services

Vejthani Hospital Bangkok recommends Assisted Reproductive Technology Center at Vejthani ART Center, the way to bring your dream come true that you will be assured by our professional service.

25 Jan 2013

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a new use of Avastin (bevacizumab) in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal cancer (mCRC).

23 Jan 2013

Novel infertility mechanism suggested in men with metabolic syndrome

Men diagnosed with the metabolic syndrome appear to have reduced fertility potential despite the absence of leucocytospermia, report researchers.

21 Jan 2013

Paying medical expenses, raising hopes, triggering fears ...

USA Today and Marketplace report on ways in which the cost of health care, especially regarding a serious illness, causes patient anxieties, challenges for the health system and new approaches within the marketplace.

21 Jan 2013

Study finds decline in spermatozoid concentration in young Spanish men

The first comparative study on the evolution of sperm quality in young Spanish men over ten years, headed by researchers at the University of Murcia, reveals that spermatozoid concentration in men between 18 and 23 years in the regions of Murcia and Almeria has dropped by an annual average of 2%.

19 Jan 2013

Scientists identify new mechanism for schistosomiasis-bladder cancer connection

About 200 million people across 75 of the poorest countries in the world are now infected by the blood parasite Schistosoma haematobium (S. haematobium). The infection causes severe urogenital disease, but also causes bladder cancer in a number of patients and why this occurs is not clear.

17 Jan 2013

Coenzyme Q10 supplement may boost male fertility

Taking a 3-month course of coenzyme Q10 supplements could improve semen quality among infertile men, show researchers.

16 Jan 2013

Leptin hormone also regulates airway diameter

A new study led by Columbia University Medical Center (CUMC) researchers has found that leptin, a hormone that plays a key role in energy metabolism, fertility, and bone mass, also regulates airway diameter.

9 Jan 2013

Fertility window research uncovers miscarriage mechanism

Research in animals has shed light on how recurrent miscarriage is related to a dysregulation of the monthly “fertility window.”

8 Jan 2013

Many male cancer patients missing out on appropriate fertility advice

Pioneering research presented at the Fertility 2013 conference today shows that a large proportion of male cancer patients are missing out on appropriate fertility advice.

4 Jan 2013

Researchers analyze impact of 3 unexpected sex determination factors

So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.

3 Jan 2013

Molecular signals make some women prone to miscarriage

Scientists have identified molecular signals that control whether embryos are accepted by the womb, and that appear to function abnormally in women who have suffered repeated miscarriages.

3 Jan 2013

Global infertility unchanged

The global rate of infertility has not significantly changed over the past 2 decades, with the exception of regions in sub-Saharan Africa and South Asia, a study shows.

2 Jan 2013

Smoking and drinking have no impact on male fertility

Alcohol drinking and smoking seem to have no significant impact on male fertility, report researchers.

19 Dec 2012

Researchers identify possible heredity mechanism that predisposes children to ALL

Researchers at the Sainte-Justine University Hospital Center and the University of Montreal have found a possible heredity mechanism that predisposes children to acute lymphoblastic leukemia (ALL), the most common type of blood cancer in children. According to their findings published in Genome Research, the presence of a genetic defect in the egg or sperm from which children having ALL arise may be a prerequisite for the disease to develop.

17 Dec 2012

Pfizer, Ligand announce FDA acceptance of bazedoxifene/conjugated estrogens NDA

Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.

14 Dec 2012